Latest News May 01, 2024 G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 01, 2024 G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
May 01, 2024 G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights